Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

- PMLiVE

Spark sets Luxturna price, igniting US affordability debate

The IRD treatment is set to cost patients $425,000 per eye

Sharp rise in mobile health app numbers

US app stores show more than 318,500 now available

- PMLiVE

Makara Health appoints Louise Finke as a director

She will support the healthcare comms agency’s strategic programme delivery

- PMLiVE

GCI Health’s Kath Kerry moves to co-MD for its London office

And the med comms agency's Hannah Morris becomes client services director

National Institute for Health and Care Excellence NICE logo

NICE to look again at Pfizer’s Besponsa after appeal

The blood cancer medicine was originally turned down on cost-effectiveness grounds

- PMLiVE

Novartis bags new breakthrough status for Kisqali in breast cancer

The Swiss pharma group’s treatment will rival Lilly’s Verzenio and Pfizer’s Ibrance if approved

Alexa: find Novo Nordisk voice-activated diabetes tech

Hitlab challenge selects patient education firm Lighthouse for $50,000 funding

Shionogi aims for digital transformation

Signs up with Accenture for seven-year work programme

- PMLiVE

The new basics

Innovative products and creative marketing  won’t help if our industry fails to address the new basics

- PMLiVE

Beverley Newbury becomes VCCP Health’s managing director

Her promotion follows nearly six years of service with the company

Storm Therapeutics bolsters its team

Professor Mark Dawson and Dr Paul Leeson join its scientific advisory board

- PMLiVE

MSD’s Keytruda wins bladder cancer indication in Japan

Becomes first anti-PD1 approved in the country for previously treated UC

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links